Chris Goodnow
Christopher Goodnow holds The Bill and Patricia Ritchie Foundation Chair as Head of the Immunogenomics Laboratory at the Garvan Institute of Medical Research, and is Professor in the School of Biomedical Sciences at UNSW Sydney. Chris trained in veterinary medicine and surgery, immunochemistry, and immunology at Sydney University and in DNA technology and molecular immunology at Stanford University. Previous positions were HHMI Investigator at Stanford University, Professor & founding Director of the Australian Phenomics Facility at the Australian National University, and Deputy Director and Executive Director of Garvan 2015-2022. Chris’ team discovered the immune tolerance checkpoints controlling antibody production, which prevent autoimmune disease and target antibodies against foreign infections. His research contributions are recognised by The 2027 Paul Ehrlich & Ludwig Darmstaedter Prize, Germany; The 2025 Crafoord Prize, Royal Swedish Academy of Sciences; 2025 Max Cooper Prize, Emory University; 2022 AAI BioLegend Herzenberg Award, American Association of Immunologists; William E. Paul Award; GSK Award for Research Excellence; Ramaciotti Medal; Health Minister’s Prize; Centenary Medal; Gottschalk Medal, Fellow Australian Academy of Science, Fellow Royal Society, and Member US National Academy of Sciences.
Outside of professional life Chris is an avid surfer, recognized for his 1980 exploration and discovery of the now legendary surf in the Mentawai Islands off Sumatra, and he enjoys spending time together with his family surfing around Bawley Point on the NSW South Coast.
Abstracts this author is presenting: